Recs

2

Palm's Sneak Attack

Investors punished smartphone maker Palm (Nasdaq: PALM  ) today, sending its shares down nearly 11%. But can you blame them?

I mean, until yesterday, no one expected Palm to report earnings until Dec. 18. Half the analysts following the stock were saying it was safe to hold, and two of these supposed experts were actually telling people to buy the stock, which most analysts thought would earn about $0.04 a share.

Yet pressure is mounting from Motorola (NYSE: MOT  ) . From Apple (Nasdaq: AAPL  ) , as its iPhone steals potential AT&T (NYSE: T  ) sales that could have gone to Palm. From Nokia (NYSE: NOK  ) -- now with in-house Navteq (NYSE: NVT  ) maps to make its Navigator and follow-on, GPS-armed phones even more attractive. And let's not forget Research In Motion (Nasdaq: RIMM  ) , making a march on Eastern Europe and stealing market share there. In short, Palm's competitive position has been deteriorating for months.

Yesterday's news may have been the final straw, as Palm confessed that "a product that the company had previously expected to have certified within the quarter" has not, in fact, been certified yet -- and importantly to both sales and earnings, not shipped to customers. Adding embarrassment to injury, Palm also cited an "unforeseen increase in warranty repair expenses" that cut deeply into its earnings for the quarter.

Maybe no one expected that Palm would report a $0.22-to-$0.24-per-share loss this month. But it seems to me that if Wall Street's finest had been doing their jobs right, they would have noticed things like products not getting certified anywhere near in time to ship this quarter. Their sales-channels checks might have detected the inordinate number of Palm phones "returned to sender" for repair -- and they might have surmised that the cost of making all these repairs would detract from Palm's Q2 profits.

In short, maybe no one predicted these problems. But certainly, someone should have. 

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 549074, ~/Articles/ArticleHandler.aspx, 5/25/2012 5:06:22 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

6/30/2010 4:00 PM
PALM.DL $5.69 Down +0.00 +0.00%
Palm CAPS Rating: *
NVT.DL $77.97 Down +0.00 +0.00%
Navteq CAPS Rating: ****
RIMM $11.00 Up +0.29 +2.71%
Research In Motion… CAPS Rating: *
T $33.69 Up +0.05 +0.15%
AT&T CAPS Rating: ***
AAPL $562.29 Down -3.03 -0.54%
Apple CAPS Rating: ***
MSI $48.02 Up +0.30 +0.63%
Motorola Solutions… CAPS Rating: **
NOK $2.82 Up +0.08 +2.92%
Nokia CAPS Rating: ***

Advertisement